The Trans-Pacific Partnership: Is It Everything We Feared for Health?
Negotiations surrounding the Trans-Pacific Partnership (TPP) trade and investment agreement have recently concluded. Although trade and investment agreements, part of a broader shift to global economic integration, have been argued to be vital to improved economic growth, health, and general welfare, these agreements have increasingly come under scrutiny for their direct and indirect health impacts.



We conducted a prospective health impact analysis to identify and assess a selected array of potential health risks of the TPP. We adapted the standard protocol for Health impact assessments (HIAs) (screening, scoping, and appraisal) to our aim of assessing potential health risks of trade and investment policy, and selected a health impact review methodology. This methodology is used to create a summary estimation of the most significant impacts on health of a broad policy or cluster of policies, such as a comprehensive trade and investment agreement.



Our analysis shows that there are a number of potentially serious health risks associated with the TPP, and details a range of policy implications for the health sector. Of particular focus are the potential implications of changes to intellectual property rights (IPRs), sanitary and phytosanitary measures (SPS), technical barriers to trade (TBT), investor-state dispute settlement (ISDS), and regulatory coherence provisions on a range of issues, including access to medicines and health services, tobacco and alcohol control, diet-related health, and domestic health policy-making.



We provide a list of policy recommendations to mitigate potential health risks associated with the TPP, and suggest that broad public consultations, including on the health risks of trade and investment agreements, should be part of all trade negotiations.
Faculty of Medicine, School of Epidemiology, Public Health and Preventive Medicine, University of Ottawa, Ottawa, ON, Canada.
Ronald
R
Labonté
Faculty of Medicine, School of Epidemiology, Public Health and Preventive Medicine, University of Ottawa, Ottawa, ON, Canada.
Ashley
A
Schram
Faculty of Medicine, School of Epidemiology, Public Health and Preventive Medicine, University of Ottawa, Ottawa, ON, Canada.
Arne
A
Ruckert
D003132:Commerce; D014943:Global Health; D062489:Health Impact Assessment; D006291:Health Policy; D006801:Humans; D007391:International Cooperation; D011634:Public Health; D018570:Risk Assessment
Global Governance for Health; Population Health; Social Determinants of Health; Trade and Investment Policy
Open Med. 2014 Aug 12;8(3):e100-1
25426174
Global Health. 2015 Oct 12;11:41
26455446
Global Health. 2013 Oct 16;9:46
24131595
Obes Rev. 2013 Oct;14 Suppl 1:120-34
24074216
Addiction. 2012 Oct;107(10):1719-21
22404183
Can J Public Health. 2015 Apr 29;106(4):e249-51
26285198
Prog Cardiovasc Dis. 2013 Nov-Dec;56(3):281-301
24267436
PLoS Med. 2012 Jan;9(1):e1001154
22253577
J Epidemiol Community Health. 2006 Sep;60(9):738-44
16905715
BMJ Open. 2016 Apr 04;6(4):e010339
27044579
J Epidemiol Community Health. 2006 Aug;60(8):655-61
16840752
Global Health. 2014 Sep 12;10:66
25213212
N Engl J Med. 2013 Mar 7;368(10):936-42
23465103
Bull World Health Organ. 2007 Mar;85(3):207-11
17486212
Am J Law Med. 2013;39(2-3):237-64
23815030
Health Policy Plan. 2008 Sep;23(5):351-60
18664524
Med J Aust. 2011 Jan 17;194(2):83-6
21241222
Int J Risk Saf Med. 2014;26(4):213-25
25420763
Public Health Nutr. 2009 Nov;12(11):2150-8
19433005
Health Policy. 2015 Jan;119(1):88-96
25217839
Bull World Health Organ. 2001;79(9):827-33
11584730